Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(9%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
8
73%
Ph phase_1
1
9%
Ph phase_2
2
18%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed4
Not yet recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (9.1%)
Phase 22 (18.2%)
N/A8 (72.7%)

Trials by Status

not_yet_recruiting19%
unknown436%
recruiting19%
completed436%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DEVICE
Total Trials
11